scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.VETIMM.2012.12.007 |
P698 | PubMed publication ID | 23332730 |
P2093 | author name string | B Dunkel | |
F M Cunningham | |||
I Aktan | |||
P2860 | cites work | The estimation of the bactericidal power of the blood | Q24651983 |
Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway | Q33384817 | ||
Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome | Q33386199 | ||
Platelets in defense against bacterial pathogens | Q33604443 | ||
Influence of platelets and platelet microbicidal protein susceptibility on the fate of Staphylococcus aureus in an in vitro model of infective endocarditis | Q34007865 | ||
NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment | Q34140079 | ||
Antimicrobial peptides from human platelets | Q34258124 | ||
Superoxide production and reducing activity in human platelets | Q35905530 | ||
Endotoxaemia: a review with implications for the horse | Q36199983 | ||
Clinical and subclinical endometritis in the mare: both threats to fertility | Q37574161 | ||
Antimicrobial peptides: the ancient arm of the human immune system | Q37823113 | ||
Circulating platelet-neutrophil complexes represent a subpopulation of activated neutrophils primed for adhesion, phagocytosis and intracellular killing | Q38460798 | ||
Endotoxin-induced digital vasoconstriction in horses: associated changes in plasma concentrations of vasoconstrictor mediators. | Q39685265 | ||
Roles of thromboxane A2 and 5-hydroxytryptamine in endotoxin-induced digital vasoconstriction in horses | Q39831717 | ||
Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor | Q40369023 | ||
Human platelets exhibit chemotaxis using functional N-formyl peptide receptors. | Q40468477 | ||
Endotoxin-induced activation of equine platelets: evidence for direct activation of p38 MAPK pathways and vasoactive mediator production | Q42513088 | ||
Selective inhibition of protein kinase C. Effect on platelet-activating-factor-induced platelet functional responses | Q42793468 | ||
The generation of superoxide anion in blood platelets in response to different forms of Proteus mirabilis lipopolysaccharide: effects of staurosporin, wortmannin, and indomethacin. | Q43678290 | ||
PKC isoenzymes in equine platelets and stimulus induced activation | Q44274021 | ||
Equine platelet CD62P (P-selectin) expression: a phenotypic and morphologic study. | Q44288535 | ||
Regulation of platelet activating factor-induced equine platelet activation by intracellular kinases | Q45357748 | ||
The blood platelets contribution to innate host defense - what they have learned from their big brothers. | Q45977268 | ||
Plasma concentrations of endotoxin and platelet activation in the developmental stage of oligofructose-induced laminitis | Q46193117 | ||
Neutrophil and platelet activation in equine recurrent airway obstruction is associated with increased neutrophil CD13 expression, but not platelet CD41/61 and CD62P or neutrophil-platelet aggregate formation. | Q48018010 | ||
Differential superoxide anion generation by equine eosinophils and neutrophils. | Q52561830 | ||
Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation. | Q53873685 | ||
Priming induces functional coupling of N -formyl-methionyl-leucyl-phenylalanine receptors in equine neutrophils | Q60129342 | ||
Effects of WEB 2086, an antagonist to the receptor for platelet-activating factor (PAF), on PAF-induced responses in the horse | Q67490061 | ||
Platelets enhance Fc(gamma) receptor-mediated phagocytosis and respiratory burst in neutrophils: the role of purinergic modulation and actin polymerization | Q71237165 | ||
Induction of superoxide anion production from monocytes an neutrophils by activated platelets through the P-selectin-sialyl Lewis X interaction | Q71657169 | ||
Antiplatelet activity of Staphylococcus aureus lipoteichoic acid is mediated through a cyclic AMP pathway | Q74172934 | ||
Response of blood platelets to Proteus mirabilis lipopolysaccharide | Q74392473 | ||
Platelet activation in ponies with airway inflammation | Q80160575 | ||
Evidence of Toll-like receptor molecules on human platelets | Q81479217 | ||
Assessment of platelet function in horses: ultrastructure, flow cytometry, and perfusion techniques | Q83872987 | ||
Inhibitory effects of lipoteichoic acid from Staphylococcus aureus on platelet function and platelet-monocyte aggregation | Q83901382 | ||
P433 | issue | 3-4 | |
P921 | main subject | Escherichia coli | Q25419 |
lipopolysaccharide | Q421804 | ||
P304 | page(s) | 209-217 | |
P577 | publication date | 2012-12-28 | |
P1433 | published in | Veterinary Immunology and Immunopathology | Q7923704 |
P1476 | title | Equine platelets inhibit E. coli growth and can be activated by bacterial lipopolysaccharide and lipoteichoic acid although superoxide anion production does not occur and platelet activation is not associated with enhanced production by neutrophils | |
P478 | volume | 152 |
Q93086874 | Antimicrobial action of autologous platelet-rich plasma on MRSA-infected skin wounds in dogs |
Q38695742 | Antimicrobial properties of platelet-rich preparations. A systematic review of the current pre-clinical evidence |
Q51660233 | Expression of surface platelet receptors (CD62P and CD41/61) in horses with recurrent airway obstruction (RAO). |
Q35261088 | Plasma components and platelet activation are essential for the antimicrobial properties of autologous platelet-rich plasma: an in vitro study |
Q38211899 | Platelets: at the nexus of antimicrobial defence |
Search more.